NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York Stock Exchange building, Mick Farrell, the CEO of ResMed, looked refreshed, despite a post ...

Learn More ResMed (ASX: RMD) shares are outperforming the market on Tuesday. In afternoon trade, the sleep disorder treatment company's shares are up 2% to $35.73. This compares favourably to a 0. ...

ResMed’s CPAP (continuous positive airway pressure) product, the AirFit N20. The California-based company, founded by Mr Farrell’s father in Sydney 35 years ago, is also listed on the ASX.

such as the AirTouch N30i next-generation CPAP mask unveiled earlier today. Capitalize on ResMed’s market opportunity and brand advantage in broader sleep health and breathing health adjacencies ...

With interactive coaching and nightly sleep data tracking, MyAir helps increase CPAP usage, with 87% of patients achieving therapy compliance. (ResMed also launched a new CPAP mask today — read ...

[Image courtesy of ResMed] ResMed (NYSE: RMD) + announced today that it launched its new AirTouch N30i continuous positive airway pressure (CPAP) mask. ResMed says it developed the AirTouch N30i ...

Flying with a CPAP machine resulted in many headaches for one journalist traveling this past summer between New York and Reykjavik on Icelandair. (Photo by Nicolas Economou/NurPhoto via Getty ...

CHANDLER – To mark Hispanic Heritage Month, the city and the Chandler International Film Festival screened the 2015 film “Spare Parts” on Sunday. The film, based on a true story, follows four Arizona ...